收藏 分销(赏)

冠状动脉内应用维拉帕米对stemi急诊pci治疗后冠脉灌注、心肌灌注和临床预后影响.docx

上传人:精**** 文档编号:10002739 上传时间:2025-04-16 格式:DOCX 页数:64 大小:759.05KB
下载 相关 举报
冠状动脉内应用维拉帕米对stemi急诊pci治疗后冠脉灌注、心肌灌注和临床预后影响.docx_第1页
第1页 / 共64页
冠状动脉内应用维拉帕米对stemi急诊pci治疗后冠脉灌注、心肌灌注和临床预后影响.docx_第2页
第2页 / 共64页
点击查看更多>>
资源描述
冠状动脉内应用维拉帕米对stemi急诊pci治疗后冠脉灌注、心肌灌注和临床预后影响(可编辑) (文档可以直接使用,也可根据实际需要修改使用,可编辑推荐下载) 上海交通大学医学院七年制硕士学位论文 缩略语表 5缩写 英文全称 中文全称 AMI Acute myocardial infarction 急性心肌梗死 STEMI ST segment elevation infarction ST 段抬高性心肌梗死 CAG Coronary arteriography 冠状动脉造影 PCI Percutaneous coronary intervention 经皮冠状动脉介入治疗 ECG Electrocardiogram 心电图 TIMI Thrombolysis in myocardial infarction 心肌梗死溶栓 IRA Infarction related artery 梗死相关动脉 LM Left main 左主干 LAD Left anterior descending artery 左前降支 LCX Left circumflex coronary artery 左回旋支 RCA Right coronary artery 右冠状动脉 LVEF Left ventricular ejection fraction 左室射血分数 MACE Major adverse cardial events 主要心脏不良事件 CTFC Corrected TIMI Frame Count 校正的 TIMI 帧数 TFG TIMI Flow Grades TIMI 血流分级 TMPG TIMI myocardial perfusion grade TIMI 心肌灌注分级 MBG Myocardial blush grade 心肌灌注显影分级 TMPFC TIMI Myocardial Perfusion Frame Count TIMI 心肌灌注帧数 IABP Intra-aortic balloon pump 主动脉内球囊反搏 CABG Coronary artery bypass graft 冠状动脉旁路移植术 TVR Target vessel revascularization 靶血管血运重建 ACEI Angiotensin-converting enzyme inhibitor 血管紧张素转换酶抑制剂 上海交通大学医学院七年制硕士学位论文 上海交通大学 学位论文原创性声明 本人郑重声明:所呈交的学位论文,是本人在导师的指导下,独立进行研究工 作所取得的成果。除文中已经注明引用的内容外,本论文不包含任何其他个人或集 体已经发表或撰写过的作品成果。对本文的研究做出重要贡献的个人和集体,均已 在文中以明确方式标明。本人完全意识到本声明的法律结果由本人承担。 学位论文作者签名:乔志卿 日期:  2021 年  5 月  2 日 2 上海交通大学医学院七年制硕士学位论文 上海交通大学 学位论文版权使用授权书 本学位论文作者完全了解学校有关保留、使用学位论文的规定,同意学校保留 并向国家有关部门或机构送交论文的复印件和电子版,允许论文被查阅和借阅。本 人授权上海交通大学可以将本学位论文的全部或部分内容编入有关数据库进行检 索,可以采用影印、缩印或扫描等复制手段保存和汇编本学位论文。 保密□,在 本学位论文属于 不保密□。 (请在以上方框内打“√”) 学位论文作者签名:乔志卿 日期:2021 年 5 月 2 日  3  年解密后适用本授权书。 指导教师签名:何奔 日期:2021 年 5 月 2 日 上海交通大学医学院七年制硕士学位论文 冠状动脉内应用维拉帕米对 STEMI 急诊 PCI 治疗后冠脉灌注、 心肌灌注和临床预后的影响 摘 要 目的:探讨急性ST段抬高心肌梗死(ST segment elevation infarction, STEMI)急诊经皮冠脉介入治疗(Percutaneous coronary intervention,PCI) 时冠脉内应用维拉帕米对冠脉灌注、心肌灌注及临床预后的影响。并研 究急性心梗急诊PCI术后心肌灌注不良(以TMPG评价)的影响因素。另观 察本中心提出的一种新的心肌灌注评价指标——TIMI心肌灌注帧数 (TIMI Myocardial Perfusion Frame Count,TMPFC)的临床影响因素,及其 在临床试验中的应用情况。 方法:本研究为前瞻性、随机、双盲、对照临床试验,连续入选100 例STEMI拟行急诊PCI的患者,随机分为维拉帕米组与对照组,维拉帕米 组在支架释放后即刻冠脉内注入维拉帕米200ug/2ml肝素生理盐水,对照 组在支架释放后即刻冠脉内注入肝素生理盐水2ml,比较两组PCI术前、 术后和冠脉内注药后的冠脉灌注[心外膜TIMI血流(TIMI Flow Grades, TFG)和校正的TIMI血流帧数计数(Corrected TIMI Frame Count,CTFC)] 和心肌灌注水平[TIMI心肌灌注分级(TIMI Myocardial Perfusion Grades, TMPG)和心肌灌注显影(TIMI Myocardial Blush Grades,MBG)];并比较 6 上海交通大学医学院七年制硕士学位论文 两组临床结果,包括PCI术后1周心超、住院期间以及随访期间主要心脏 不良事件(Major adverse cardiac events,MACE)发生率。 所有患者根据PCI术后TMPG分级,分为心肌灌注不良组(TMPG0-2 级,n=30)和心肌灌注正常组(TMPG3级,n=61),比较两组基本临床 资料和造影结果以及介入结果,并对各因素做logistic回归,总结急性心 梗急诊PCI术后心肌灌注不良的影响因素。 采用上述同样方法,将所有患者根据TMPFC值分为TMPFC≤90和 TMPFC>90两组,观察各临床因素对TMPFC的影响;并将TMPFC应用 于上述随机双盲对照试验中,观察维拉帕米干预后TMPFC是否和TMPG 产生一样的变化。 结果:100例病人中有91例患者最终入选本试验,另9位因造影图像 质量未达到试验要求而排除,入选患者中男性76例,女性15例,年龄38~ 84(62.3±11.8)岁,维拉帕米组47人,对照组44人,两组术中应用替罗非 班的情况对照组多于维拉帕米组(29.5 %vs10.6 %,p=0.0237),其他临 床特征和造影特征两组均无显著差异。冠脉支架释放后即刻冠脉灌注 (CTFC、TFG)和心肌灌注水平(TMPG、MBG)两组间均无显著差异; 但冠脉内注入维拉帕米后CTFC(p=0.0105)、TFG(p=0.0071)、TMPG (p=0.0315)和 MBG(p=0.0261)均有显著改善;经对替罗非班应用影 响因素校正后,CTFC(P=0.0487)仍有显著改善,TFG(P=0.069)、 MBG(P=0.0891)有改善的趋势,而TMPG(P=0.123)两组间无显著差 7 上海交通大学医学院七年制硕士学位论文 异。两组PCI术后1周心超结果(LVEF、LVEDD、LVESD)未见显著差 异;两组院内MACE事件发生率未达到统计学差异(p=0.6127),1月和 3月随访期MACE发生率两组亦未见显著差异(p=0.7060和p=0.894)。 心肌灌注不良组(TMPG0-2级)高血压比例更多(80%vs54.1%, p=0.0163),心梗部位以非前壁心梗为多(70%vs29.5%,p=0.002);造 影结果中心肌灌注不良组梗塞相关血管为RCA者更多(63.3%vs18%, p<0.0001),术前CTFC值(97.7 ±±26.4,p=0.0414)和术前 MBG0级的比例(93.3%vs75.4%,p=0.0268)也是心肌灌注不良组更高; 介入治疗中心肌灌注不良组使用替罗非班的比例更高(33.3 %vs13.1 %, p=0.0228);单因素回归分析显示高血压、非前壁心梗、发病至球囊开 通时间、犯罪血管为RCA、术中需使用替罗非班、术前MBG分级均是PCI 术后心肌灌注不良(TMPG分级差)的预测因素,但多因素的Logistic回 归分析发现,仅发病至球囊开通时间是PCI术后心肌灌注不良的独立危险 因素。 和TMPG的影响因素相似,TMPFC的影响因素有非前壁心梗、犯罪 血管为RCA、术前CTFC、TFG、MBG分级均是PCI术后TMPFC的影响因 素,其中非前壁心梗是PCI术后TMPFC数值偏高的独立危险因素 (p=0.0124)。但和TMPG不同的是发病至球囊开通时间并不是TMPFC的 影响因素。TMPFC在上述临床试验中的应用,表现出和TMPG、MBG相 似的结果,冠脉内注入维拉帕米后TMPFC有显著改善(108.7 ±44.9 vs 8 上海交通大学医学院七年制硕士学位论文 123.3 ±57.8,p=0.0216),而注入对照药物时未见显著差异(134.0 ±66.7 vs 141.8 ±74.4,p=0.7215),这和TMPG一致;但给药后维拉帕米组和对 照组的TMPFC比较,前者有优于后者的趋势,但无统计学差异(108.7 ±44.9 vs 134.0 ±66.7,p=0.0899),而TMPG却仍表现出前者显著优于后 者的差异。 结论:对于急性ST段抬高心肌梗死行急诊PCI治疗的患者,冠状动 脉内应用维拉帕米可显著改善冠脉灌注,并有改善心肌灌注的趋势,但 对PCI术后心功能和短期临床预后的影响未见显著差异。 高血压、非前壁心梗、犯罪血管为RCA、术前CTFC及术前MBG分 级、发病至球囊开通时间均是PCI术后TMPG的影响因素,其中发病至球 囊开通时间是PCI术后TMPG分级低的独立危险因素,发病至球囊开通时 间越长,PCI术后TMPG分级越低。 和TMPG的影响因素相似,TMPFC的影响因素有非前壁心梗、犯罪 血管为RCA、术前CTFC、TFG和MBG分级,其中非前壁心梗是PCI术后 TMPFC数值偏高的独立危险因素;但和TMPG不同的是发病至球囊开通 时间并不是TMPFC的影响因素。TMPFC在临床试验的应用中体现了和 TMPG类似结果,但其价值有待进一步研究。 关键词:心肌梗死,经皮冠状动脉介入,维拉帕米,心肌灌注,冠 脉灌注,影响因素 9 上海交通大学医学院七年制硕士学位论文 Effect Of Intracoronary Verapamil On Coronary Flow,Myocardial Perfusion and Clinical Outcome During Percutaneous Coronary Intervention For Acute Myocardial Infarction ABSTRACT Objective To compare the effects of intracoronary verapamil on coronary flow,myocardial perfusion and clinical outcome with acute ST elevation myocardial infaretion (STEMI);and to study influencing factors of lower myocardial perfusion levels as evaluated by TIMI myocardial perfusion grade(TMPG)of STEMI patients undergoing primary PCI.And to observe influencing factors of TMPFC,a new method of assessing myocardial perfusion and compare it with TMPG in clinical test. Methods A total of 100 consecutive STEMI patients undergoing primary PCI were randomly assigned to intracoronary verapamil or to 10 上海交通大学医学院七年制硕士学位论文 intracoronary heparinised saline after deploying stent. Thrombolysis in Myocardial Infarction (TIMI) flow grade(TFG),corrected TIMI frame count (CTFC), TIMI myocardial perfusion grade (TMPG),TIMI Myocardial Blush Grades( MBG) were assessed pre- and post-PCI and after study drug administration.  Echocardiography  were  performed  one  week  after infarction, revascularization, angina pectoris,heart failure, readmission) in hospital and 3 months follow-up were compared between two groups. All patients were divided two groups by TMPG after PCI.One group was lower myocardial perfusion levels(TMPG 0-2,n=30),the other was normal myocardial perfusion levels(TMPG3,n=61).We compare Baseline characteristics and Angiographic characteristics between two groups.And logistic regression analysis was employed to determine the independent predictors of low TMPG after PCI. As the same way,all patients were divided two groups by TMPFC.One was TMPFC ≤ 90,the other was TMPFC > 90. We compare Baseline characteristics and Angiographic characteristics between two groups.And TMPFC was applied in clinical test above,in order to observe the difference between TMPFC and TMPG in the test. Results Ninety one STEMI patients were enrolled,and nine patients 11 上海交通大学医学院七年制硕士学位论文 were excluded for quality of coronary angiograms after PCI.Among 91 patients,76 patients were male and 15 patients were femal aged from 38 to 84ys.Except for using Tirofiban(verapamil group10.6 % vs control group29.5 %,p=0.0237), Baseline characteristics and Angiographic characteristics were not significantly different between two groups.CTFC、TFG、TMPG、MBG after PCI were were not significantly different between two groups.But after study drug administration, Verapamil group was superior to controll group in terms of CTFC(p=0.0105)、TFG(p=0.0071)、TMPG(p=0.0315)and MBG ( p=0.0261). After correcting factor of using Tirofiban, only CTFC ( p=0.0487 ) was still significantly different between two group,TFG (P=0.069)and MBG(P=0.0891)had a same trend,while TMPG(P=0.123) was not significantly different between two groups. LVEF、LVEDD、LVESD after PCI were not significantly different between two groups.The MACE rate in hospital was similar between two groups (p=0.6127).The combined incidence of MACE during 1-month and 3-month follow-up was not significantly lower in the verapamil group compared with control group (p=0.7060 and p=0.894). More hypertensions(80%vs54.1%,p=0.0163)and non-anterior wall infarction( 70%vs29.5%, p=0.002) were observed in lower myocardial perfusion levels group.Infarction related arteries were RCA more frequently 12 上海交通大学医学院七年制硕士学位论文 in lower myocardial perfusion levels group than normal myocardial perfusion levels group(63.3%vs18%,p<0.0001).CTFC(97.7 ±±26.4, p=0.0414)and rate of MBG 0 grade(93.3%vs75.4%,p=0.0268)before PCI were higher in lower myocardial perfusion levels group.Rate of using tirofiban during PCI was higher in lower myocardial perfusion levels group than normal myocardial perfusion levels group(33.3 %vs13.1%,p=0.0228). Univariate logistic regression analysis of the association between clinical and angiographic characteristics, and TMPG shows hypertensions, non-anterior wall infarction,onset to balloon time, RCA as culprit vessel,using tirofiban and MBG before PCI were correlated with the lower myocardial perfusion after PCI.Multivariate logistic regression analysis shows only onset to balloon time was the strong predictor of low TMPG after PCI independent of other prognostic factors. Influencing factors of TMPFC included non-anterior wall infarction , RCA as culprit vessel and CTFC、TFG、MBG before PCI; and non-anterior wall infarction was the strong predictor of poor TMPFC after PCI independent of other prognostic factors(p=0.0124).But onset to balloon time was not influencing factor of TMPFC.After intracoronary verapamil, TMPFC was significantly better than that before administration(108.7 ±44.9 vs 123.3 ±57.8,p=0.0216),but it was not better after control drug administration 13 上海交通大学医学院七年制硕士学位论文 (134.0 ±66.7 vs 141.8 ±74.4,p=0.7215).It was same as TMPG.We compared TMPFC after study drug administration between verapamil group and control group, it was not siginificantly different between two groups (108.7 ±44.9 vs 134.0 ±66.7,p=0.0899).While TMPG was significantly different between two groups. Conclusion Administration of intracoronary verapamil during primary PCI significantly improves postprocedural coronary flow as evaluated by CTFC in STEMI patients.And it had a same trend in myocardial perfusion as evaluated by MBG,but it was not statistical significance. Intracoronary verapamil is not significantly superior left ventricular function and short-time clinical prognosis compared with the controll in patients with STEMI undergoing primary PCI. Hypertensions, non-anterior wall infarction ,RCA as culprit vessel, onset to balloon time,CTFC ,MBG before PCI were influential factors of low myocardial perfusion(TMPG0-2).And onset to balloon time was the independent predictor of low myocardial perfusion.More onset to balloon time,lower TMPG. Non-anterior wall infarction , RCA as culprit vessel and CTFC、TFG、 MBG before PCI were influential factors of TMPFC. And non-anterior wall infarction was the independent predictor of poor TMPFC,while onset to 14 上海交通大学医学院七年制硕士学位论文 balloon time was not influential factors of TMPFC.TMPFC had similar change with TMPG in our clinical test,but it needs more study to consummate this new method of assessing myocardial perfusion. KEY WORDS  myocardial  infarction , percutaneous  coronary intervention, verapamil, myocardial perfusion, coronary flow,influential factor 15 上海交通大学医学院七年制硕士学位论文 前  言 大规模的临床研究表明,急性心梗早期行急诊PCI能挽救缺血心肌,从而改善近 期和远期的临床预后。但约10%~30%的患者PCI术后并发无再流或慢血流现象,心外 膜血管未能达到TIMI3级血流,即使达到TIMI3级血流,部分病人也未必达到完全的 心肌组织水平灌注,结果其再梗、恶性心律失常和心衰的发生率和死亡率明显增加, 严重影响AMI患者的预后[1]。因此治疗STEMI的最终目的是及时、充分的恢复心肌组 织水平灌注,从而减轻心肌重构、改善心功能,AMI的理想再灌注治疗应当是在冠 脉已再通的基础上,实现心肌水平的完全再灌注。 目前评价冠脉灌注的影像学方法有:Gibson等提出的校正的TIMI帧数计数 (CTFC)用帧数将冠脉血流灌注量化[2],CTFC较TIMI分级在评价血流灌注方面进 一步量化,客观性和准确性增强。评价心肌灌注的影像学方法有:由Gibson等[1]提出 的以心肌造影剂进出时间为基础的心肌组织灌注程度的分级方法-TIMI心肌灌注 (TIMI Myocardial Perfusion Grading,TMPG)分级;以及 Van’t Hof等[3]提出的另一种以 心肌显影密度为基础的MBG分级方法。 近年来,改善心肌灌注的干预措施进展较快,针对心肌灌注的临床试验,包括 药理性方法,如糖蛋白IIb/IIIa拮抗剂、腺苷、硝普钠、尼可地尔、尼卡地平、链激 酶、维拉帕米等;机械性方法,如远端保护装置和抽吸导管等。其中维拉帕米的应 用较多,但对维拉帕米是否能真正改善PCI术后冠脉灌注、心肌灌注和临床预后还存 在争议,而且既往的临床试验多为回顾性,缺少前瞻性、随机、双盲、对照的临床 研究,本研究就是设计一个临床试验来评价维拉帕米对冠脉灌注和心肌灌注的影响。 多项研究表明年龄、心功能不全、IRA重建时间、梗死前心绞痛、Q波计数、ST 段回落不良等因素是急诊PCI病人术后心功能恢复和主要心血管病事件的影响因素; 但这些因素是否均会影响心肌组织微灌注尚不明确。既往的研究多以无/慢血流作为 心肌组织灌注不足的评价,而这是以TIMI≤2级作为灌注不足,这并非心肌水平灌注 的评价,本研究以TMPG为评价心肌水平灌注的指标,通过比较心肌水平灌注不良病 16 上海交通大学医学院七年制硕士学位论文 人(TMPG≤2级)与心肌水平灌注正常病人(TMPG3级)的临床资料进行分析,以 探讨导致心肌组织水平灌注不良的危险因素。 评价心肌水平灌注的影像学方法主要是Gibson等提出的TMPG和Van’t Hof等提 出的MBG方法,但这两种心肌水平再灌注评价方法主观性较强无法消除各观察者之 间对血流判断上的差异,所以目前尚无一种良好的心肌水平灌注的造影评价指标, 本中心提出了一种新的心肌灌注评价系统——TMPFC,本中心之前已证实TMPFC对 临床预后具有重要的预测价值[4],本研究的目的是观察影响TMPFC的临床因素,并 将这一新方法应用于临床试验中,与TMPG进行比较。 总之,本研究旨在评价冠脉内应用维拉帕米对急性心梗介入治疗后冠脉灌注、 心肌灌注和临床预后的影响。同时观察引起心肌灌注不良的可能存在的因素。并将 一种新的心肌灌注评价指标(TMPFC)在临床试验中应用。 参考文献: 1.Gibson CM, Cannon CP, Murphy SA, et al.Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000;101:125–130. 2.Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation, 1996,93:879–888. 3.van‘t Hof AWJ, Liem A, Suryapranata H, et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Circulation,1998, 97: 2302–2306. 4.He B, Ding S, Pu J. TIMI myocardial perfusion frame count - a new method for assessing myocardial perfusion. Catheter Cardiovasc Interv 2007; 69:S16. 17 上海交通大学医学院七年制硕士学位论文 第一部分:冠状动脉内应用维拉帕米对STEMI急诊PCI治疗后 冠脉灌注、心肌灌注和临床预后的影响 ——前瞻性、随机、双盲、对照临床研究 引言 大规模临床研究表明,急性心梗(AMI)早期行急诊PCI能挽救缺血心肌,从而 改善近期和远期的预后。然而,AMI急诊
展开阅读全文

开通  VIP会员、SVIP会员  优惠大
下载10份以上建议开通VIP会员
下载20份以上建议开通SVIP会员


开通VIP      成为共赢上传
相似文档                                   自信AI助手自信AI助手

当前位置:首页 > 行业资料 > 医学/心理学

移动网页_全站_页脚广告1

关于我们      便捷服务       自信AI       AI导航        抽奖活动

©2010-2025 宁波自信网络信息技术有限公司  版权所有

客服电话:4009-655-100  投诉/维权电话:18658249818

gongan.png浙公网安备33021202000488号   

icp.png浙ICP备2021020529号-1  |  浙B2-20240490  

关注我们 :微信公众号    抖音    微博    LOFTER 

客服